Are you Dr. Wang?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
5323 Harry Hines Boulevard
Dallas, TX 75390Phone+1 214-645-4673Fax+1 214-645-2615
Summary
- Dr. Jue Wang, MD is an oncologist in Dallas, Texas. He is an Assistant Professor at University of Nebraska Medical.
Publications & Presentations
PubMed
- Successful Management of Disseminated Intravascular Coagulation in Metastatic Castrate-Resistant Prostate Cancer With Lutetium-177: A Case Report and Review of the Lit...Jie Zheng, Chidera Ibezue, Nghi Nguyen, Qi Cai, Qian Qin
Cureus. 2024-12-01 - On reactive Ion Etching of Parylene-C with Simple Photoresist Mask for Fabrication of High Porosity Membranes to Capture Circulating and Exfoliated Tumor Cells.Inad Rabadi, David Carpentieri, Jue Wang, Frederic Zenhausern, Jian Gu
Micromachines. 2024-04-13 - 3 citationsTrastuzumab and Pertuzumab in Patients with Non-Breast/Gastroesophageal HER2-Amplified Tumors: Results from the NCI-MATCH ECOG-ACRIN Trial (EAY131) Subprotocol J.Roisin M Connolly, Victoria Wang, David M Hyman, Petros Grivas, Edith P Mitchell
Clinical Cancer Research. 2024-04-01
Press Mentions
Comparison of Clinicopathological Characteristics and Response to Neoadjuvant Systemic Therapy in Patients with HER2-Low-Positive and HER2-Zero Breast CancerJanuary 19th, 2023
NMPA Approves IND Application for CT103A, a Fully-Human BCMA CAR-T for the Treatment of Relapsed/Refractory Multiple Myeloma Co-Developed by IASO BIO and Innovent BiologicsOctober 2nd, 2019- Clinical Results of Fully Human BCMA CAR-T for the Treatment of Relapsed/Refractory Multiple Myeloma Co-Developed by IASO BIO and Innovent Presented at the 2019 ASCO and EHA Annual MeetingsJune 19th, 2019
- Join now to see all
